Recent Updates
Recently added Catalysts
TTRX Positive Sentiment

Turn Therapeutics to Present at Jefferies Global Healthcare Conference in London

Key Takeaway: Turn Therapeutics Inc. announced that CEO Bradley Burnam will present at the Jefferies Global Healthcare Conference in London. The presentation is scheduled for November 16, 2026, from 10:30 AM to 10:55 AM ET. This event underscores the company's focus on developing targeted therapies for inflammatory skin diseases.

Market Sentiment Analysis

POSITIVE FACTORS

  • Turn Therapeutics is actively engaging with investors.
  • The presentation highlights the company's innovative therapies.
  • CEO Bradley Burnam will represent the company at a major conference.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~20 mo
Low dilution risk
Lead asset
GX-03
Phase 2 · Covid19

Full Press Release Details

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced that Bradley Burnam, Chief Executive Officer, will deliver a company presentation as part of the Jefferies Global Healthcare Conference in London. Presentation details are as follows: Date: Monday, November 16, 2026 Time: 10:30 AM – 10:55 AM ET (3:30 PM – 3:55 PM GMT) The Company will

Frequently Asked Questions

When will Turn Therapeutics present at the conference?

The presentation is scheduled for November 16, 2026.

Who will represent Turn Therapeutics at the conference?

CEO Bradley Burnam will deliver the presentation.

What is the focus of Turn Therapeutics?

The company develops targeted therapies for inflammatory skin diseases.

What time is the presentation at the conference?

The presentation will take place from 10:30 AM to 10:55 AM ET.

Last updated: Nov 16, 2026